Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)

Saudi Arabia · Delayed Price · Currency is SAR

30.10

-0.36 (-1.18%)

Oct 15, 2026, 3:10 PM AST

Market Cap	3.59B +0.9%
Revenue (ttm)	1.74B +1.1%
Net Income	214.39M +183.8%
EPS	1.80 +183.8%
Shares Out	119.36M
PE Ratio	16.76
Forward PE	14.44
Dividend	0.35 (1.16%)
Ex-Dividend Date	Jun 10, 2026

Volume	454,510
Open	30.30
Previous Close	30.46
Day's Range	29.72 - 30.32
52-Week Range	24.96 - 33.32
Beta	0.39
Analysts	Hold
Price Target	35.42 (+17.67%)
Est. Earnings	Nov 5, 2026

About TADAWUL:2070

Saudi Pharmaceutical Industries and Medical Appliances Corporation develops, manufactures, and markets medicinal and pharmaceutical products in the Kingdom of Saudi Arabia, the Middle East, Egypt, Algeria, and Morocco. The company operates through Pharmaceutical Manufacturing, Trading and Distribution Services, and Healthcare Services segments. The company is involved in the sale, marketing, and distribution of pharmaceutical, veterinary, medical equipment, and cosmetics products; and operates and maintains a secondary care hospital. In additio... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1986

Country Saudi Arabia

Stock Exchange Saudi Stock Exchange

Ticker Symbol 2070

Full Company Profile

Financial Performance

In 2025, TADAWUL:2070's revenue was 1.71 billion, an increase of 1.47% compared to the previous year's 1.68 billion. Earnings were 184.36 million, an increase of 651.43%.

Financial Statements

Analyst Summary

According to 4 analysts, the average rating for 2070 stock is "Hold." The 12-month stock price target is SAR 35.42, which is an increase of 17.67% from the latest price.

Price Target

SAR 35.42

(17.67% upside)

Analyst Consensus: Hold

Stock Forecasts